BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1059 related articles for article (PubMed ID: 24934638)

  • 21. Preservation of fertility in females with haematological malignancy.
    Donnez J; Dolmans MM
    Br J Haematol; 2011 Jul; 154(2):175-84. PubMed ID: 21564077
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Utility of gonadotropin-releasing hormone agonists for fertility preservation in young breast cancer patients: the benefit remains uncertain.
    Turner NH; Partridge A; Sanna G; Di Leo A; Biganzoli L
    Ann Oncol; 2013 Sep; 24(9):2224-35. PubMed ID: 23709175
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fertility and adjuvant treatment in young women with breast cancer.
    Partridge AH; Ruddy KJ
    Breast; 2007 Dec; 16 Suppl 2():S175-81. PubMed ID: 17804236
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fertility conservation in breast cancer patients.
    Lawrenz B; Henes M; Neunhoeffer E; Kraemer B; Fehm T
    Womens Health (Lond); 2011 Mar; 7(2):203-12. PubMed ID: 21410346
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chemotherapy and fertility.
    Blumenfeld Z
    Best Pract Res Clin Obstet Gynaecol; 2012 Jun; 26(3):379-90. PubMed ID: 22281514
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A survey on fertility management in young women of reproductive age treated with chemotherapy.
    Abe A; Kuwahara A; Iwasa T; Nishimura M; Irahara M
    Int J Clin Oncol; 2016 Dec; 21(6):1183-1190. PubMed ID: 27402102
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fertility Preservation in Breast Cancer.
    O'Donoghue C; Quinn GP; Lee MC
    South Med J; 2017 Oct; 110(10):621-626. PubMed ID: 28973701
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Gonadotropin-releasing hormone agonists for ovarian protection during cancer chemotherapy: systematic review and meta-analysis.
    Senra JC; Roque M; Talim MCT; Reis FM; Tavares RLC
    Ultrasound Obstet Gynecol; 2018 Jan; 51(1):77-86. PubMed ID: 29055060
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prevention of chemotherapy-induced ovarian damage: possible roles for hormonal and non-hormonal attenuating agents.
    Roness H; Kalich-Philosoph L; Meirow D
    Hum Reprod Update; 2014; 20(5):759-74. PubMed ID: 24833728
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Medical approaches to preservation of fertility in female cancer patients.
    Del Mastro L; Giraudi S; Levaggi A; Pronzato P
    Expert Opin Pharmacother; 2011 Feb; 12(3):387-96. PubMed ID: 21254946
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Gonadotropin-releasing hormone analogues for the prevention of chemotherapy-induced premature ovarian failure in breast cancer patients.
    Conte B; Del Mastro L
    Minerva Ginecol; 2017 Aug; 69(4):350-356. PubMed ID: 28398024
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Issues with Fertility in Young Women with Breast Cancer.
    Christian N; Gemignani ML
    Curr Oncol Rep; 2019 May; 21(7):58. PubMed ID: 31098718
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Update on fertility preservation in young women undergoing breast cancer and ovarian cancer therapy.
    Lambertini M; Ginsburg ES; Partridge AH
    Curr Opin Obstet Gynecol; 2015 Feb; 27(1):98-107. PubMed ID: 25490381
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Preliminary results of a counselling programme for fertility preservation in female cancer patients: The experience of the GEMME DORMIENTI network.
    Ciccarone M; Hohaus S; Pulsoni A; Cavaceppi P; Franzò S; Fabbri R; Cudillo L; Battistini R; Di Rocco A; Annibali O; Cox MC; Provenzano I; Abruzzese E; Renzi D; Tesei C; Anticoli Borza P; Cuccaro A; Andriani A; D'Elia GM; Facchiano A; Marchetti P; Cantonetti M
    Eur J Cancer Care (Engl); 2020 Jan; 29(1):e13174. PubMed ID: 31571303
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Endocrine prevention of chemotherapy-induced ovarian failure.
    Blumenfeld Z; Evron A
    Curr Opin Obstet Gynecol; 2016 Aug; 28(4):223-9. PubMed ID: 27253235
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Infertility in reproductive-age female cancer survivors.
    Levine JM; Kelvin JF; Quinn GP; Gracia CR
    Cancer; 2015 May; 121(10):1532-9. PubMed ID: 25649243
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Advances in the Treatment and Prevention of Chemotherapy-Induced Ovarian Toxicity.
    Cho HW; Lee S; Min KJ; Hong JH; Song JY; Lee JK; Lee NW; Kim T
    Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33096794
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Oocyte/embryo cryopreservation before chemotherapy for breast cancer].
    Decanter C; Gligorov J
    Gynecol Obstet Fertil; 2011 Sep; 39(9):501-3. PubMed ID: 21835668
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fertility preservation in female cancer patients: an emerging challenge for physicians.
    Caserta D; Ralli E; Matteucci E; Marci R; Moscarini M
    Panminerva Med; 2014 Mar; 56(1):85-95. PubMed ID: 24637474
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Breast cancer and fertility: critical review, considerations and perspectives].
    This P
    Bull Cancer; 2008 Jan; 95(1):17-25. PubMed ID: 18230566
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 53.